ABOUT THE STUDY
The Lundquist Institute is excited to have been chosen by the US National Institute of Health to participate in its national scientific effort to rapidly develop vaccines and treatments for COVID-19.
Lundquist’s role will be to serve as one of several phase 3 study sites in Los Angeles that is testing a promising new investigational vaccine, ChAdOx1, which was developed by Oxford University and AstraZenaca.
Our phase 3 study is the last step in testing prior to licensing. If our study shows the vaccine is effective, that will result in the widespread use of the vaccine to prevent illness.
SAFETY
The safety and privacy of our volunteers are our no. 1 priority. Period. While we must acknowledge that the development of new treatments and vaccines always carries some risk, everything possible will be done to minimize these risks. As with other vaccines, prior studies have shown that mild side effects of localized pain and swelling are common, as well as fatigue or fever as your body responds to the vaccine.
The vaccine does not include the virus that causes COVID-19, and therefore it can NOT result in a study volunteer getting the infection.
HOW THE STUDY IS ADMINISTERED
Our study is a double-blind, placebo-controlled trial, which means that of the volunteers enrolled, two-thirds of them will get the study vaccine and one-third will get a placebo, or a harmless injection of saltwater. Neither the volunteer or those administering the vaccine or placebo injection will know which the volunteer is receiving.
WHAT YOU CAN EXPECT
The study will be administered in two separate doses; one on the first day and one four weeks later. After receiving the vaccine or placebo injection, our researchers will observe all study volunteers for up to two years for infection. If there are significantly less volunteers in the vaccine group than the placebo group that become ill, this will serve as solid evidence that this vaccine is effective.
Volunteer for the Study:
Have more questions?
Location
1124 W. Carson St.
Torrance, CA 90502
Contact
COVID@lundquist.org
(310) 222-3848.
Press Inquiries?
Press@helpstopcovid.la
Privacy Policy